FdaApplication
ANDA 213313
Identifiers
- fda_app_no: ANDA213313
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | ANDA |
| approval_date | 2021-04-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PREGABALIN | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE;ORAL |
| PREGABALIN | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE;ORAL |
2 products